Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 6 | 5 |
| List of Tables | 9 | 1 |
| List of Figures | 10 | 1 |
| Introduction | 11 | 1 |
| Contract Manufacturing Organizations in the Americas API Manufacturing | 12 | 2 |
| Introduction | 12 | 1 |
| Steps Involved in Outsourcing API Manufacturing to Contract Manufacturing Organizations | 12 | 1 |
| The US Contract Manufacturing Organization Market | 12 | 2 |
| The Americas Active Pharmaceutical Ingredients Market | 14 | 25 |
| Market Overview | 14 | 1 |
| API Classification Based on Synthesis Routes | 14 | 1 |
| Synthetic API | 14 | 1 |
| Biotech API | 14 | 1 |
| Classification Dependent on Customer Base | 15 | 1 |
| Industry Structure | 15 | 1 |
| Pricing and reimbursement in Americas | 16 | 1 |
| The US Healthcare System - Introduction | 16 | 1 |
| Health Insurance | 16 | 1 |
| Public or Government Health Insurance | 16 | 1 |
| Private Health Insurance | 16 | 1 |
| Brazil Healthcare System - Introduction | 17 | 1 |
| Public Insurance | 17 | 1 |
| Private Insurance | 17 | 1 |
| The Americas API Market Drivers | 17 | 1 |
| Upcoming Patent Expiries are Expected to Alter the API Market Dynamics in the Americas | 17 | 1 |
| Increasing Uptake of Biologics across Different Therapeutic Areas and Government Initiatives for Biomedical Research to Boost the API Revenues | 17 | 1 |
| Mergers and Acquisitions have Increased Significantly in the American Pharmaceutical Industry | 18 | 1 |
| Growth in the Pharmaceutical Industry and Increasing Elderly Population are Driving the Growth of the Americas API Market | 18 | 1 |
| The Americas API Market Restraints | 18 | 1 |
| Economic Downturn has Restricted Investment in the Pharmaceutical Industry | 18 | 1 |
| Lack of Cheap Labor, High Costs and Saturation of the Market are Likely to Hinder New Drug Development in the Region | 18 | 1 |
| Regulatory Changes Lead to Delays in the Launch of New Drugs | 18 | 1 |
| Patent Expiries and Increased Consumption of Generics Threatens API Revenue Growth | 18 | 1 |
| Huge Deficits Provoke Cuts in Healthcare Reimbursement | 19 | 1 |
| API Total Revenue Analysis in the Americas | 20 | 2 |
| The Americas Revenue Share by Product Types | 22 | 1 |
| The Americas Synthetic API Total Synthetic Revenue Analysis (2005 2017) | 23 | 3 |
| The Americas Synthetic API Revenue Share Analysis by Regions 2011 | 26 | 1 |
| The Americas Synthetic API Revenue Share Trend Analysis by Region | 27 | 1 |
| The Americas Synthetic API Market Revenue Share Analysis by Customer Base in 2011 | 28 | 1 |
| The Americas Synthetic API Revenue Trend Analysis 2005 2017 | 29 | 2 |
| The Americas Biotech API Market Analysis | 31 | 1 |
| The Americas Biotech API Revenue Analysis 2005 2017 | 31 | 2 |
| The Americas Biotech API Revenue Share Analysis by Region 2011 | 33 | 1 |
| The Americas Biotech API Revenue Share Trend Analysis by Region 2011 | 34 | 1 |
| The Americas Biotech API Market Revenue Analysis by Customer Base | 35 | 1 |
| The Americas Biotech API Market Revenue Share Analysis by Customer Base | 35 | 1 |
| Patent Expiry of Leading Biologics in the Americas | 36 | 1 |
| The Americas Biotech API Revenue Trend Analysis 2005 2017 | 37 | 2 |
| North American Active Pharmaceutical Ingredients Market | 39 | 13 |
| North American API Market Overview | 39 | 1 |
| North American API Market Drivers | 39 | 1 |
| Continuous Growth in the Pharmaceutical Industry Sustains the API Market s Growth in North America | 39 | 1 |
| Generic Sector Spurs the Growth of the North American API Market | 39 | 1 |
| Increasing Focus on Biological Drugs Helps the API Market s Revenue Growth | 39 | 1 |
| North American API Market Restraints | 39 | 1 |
| Recent Economic Slowdown has Restricted the Growth of the Pharmaceutical Industry | 39 | 1 |
| High Cost of New Drug Development Hampers Innovation | 39 | 1 |
| Patent Expiries of Blockbuster Molecules will Contain the Growth of the API Market in North America | 40 | 1 |
| North American Total API Revenue Analysis based on Synthesis Routes 2005 2017 | 41 | 2 |
| North American API Revenue Share Analysis by Product Types 2005 2017 | 43 | 1 |
| North American API Revenue Analysis Dependent on Customer Base | 44 | 1 |
| North American Synthetic API Revenue Analysis by Customer Base, 2005 2017 | 44 | 2 |
| North American Synthetic API Market Revenue Share Analysis by Customer Base, 2005 2017 | 46 | 1 |
| North American Biotech API Revenue Analysis by Customer Base, 2005 2017 | 47 | 2 |
| North American Biotech API Revenue Share Analysis by Customer Base, 2005 2017 | 49 | 1 |
| North American API Revenue Share Analysis by Therapeutic Applications | 50 | 2 |
| The US Active Pharmaceutical Ingredients Market | 52 | 10 |
| The US API Market Overview | 52 | 1 |
| The US Total API Revenue Analysis Based on Synthesis Routes 2005 2017 | 52 | 3 |
| The US API Revenue Share Analysis by Product Types 2005 2017 | 55 | 1 |
| The US API Revenue Analysis Dependent on Customer Base | 56 | 1 |
| The US Synthetic API Revenue Analysis by Customer Base, 2005 2017 | 56 | 2 |
| The US Synthetic API Market Revenue Share Analysis by Customer Base, 2005 2017 | 58 | 1 |
| The US Biotech API Revenue Analysis by Customer Base, 2005 2017 | 59 | 2 |
| The US Biotech API Revenue Share Analysis by Customer Base, 2005 2017 | 61 | 1 |
| Canadian Active Pharmaceutical Ingredients Market | 62 | 9 |
| Canadian API Market Overview | 62 | 1 |
| Canadian Total API Revenue Analysis based on Synthesis Routes 2005 2017 | 62 | 2 |
| Canadian API Revenue Share Analysis by Product Types 2005 2017 | 64 | 1 |
| Canadian API Revenue Analysis Dependent on Customer Base | 65 | 1 |
| Canadian Synthetic API Revenue Analysis by Customer Base, 2005 2017 | 65 | 2 |
| Canadian Synthetic API Market Revenue Share Analysis by Customer Base, 2005 2017 | 67 | 1 |
| Canadian Biotech API Revenue Analysis by Customer Base, 2005 2017 | 68 | 2 |
| Canadian Biotech API Revenue Share Analysis by Customer Base, 2005 2017 | 70 | 1 |
| South and Central America Active Pharmaceutical Ingredients Market | 71 | 12 |
| South and Central American API Market Overview | 71 | 1 |
| South and Central America API Market Drivers | 71 | 1 |
| Government Initiatives and Growing Investments in the Pharmaceutical Industry Gives a Boost to API Market Growth | 71 | 1 |
| Improvement in Regulatory Environment | 71 | 1 |
| Increasing Number of Clinical Trials Leading to Market Growth | 71 | 1 |
| Ageing Population and Increasing Prevalence of Lifestyle Diseases Fuel Market Growth | 71 | 1 |
| South and Central American API Market Restraints | 72 | 1 |
| Import Dependence for APIs Restricts Market Growth | 72 | 1 |
| Delay in Regulatory Processes Hinders the Industry Growth | 72 | 1 |
| South and Central American Total API Revenue Analysis based on Synthesis Routes 2005 2017 | 72 | 2 |
| South and Central American API Revenue Share Analysis by Product Types 2005 2017 | 74 | 1 |
| South and Central American API Revenue Analysis Dependent on Customer Base | 75 | 1 |
| South and Central American Synthetic API Revenue Analysis by Customer Base, 2005 2017 | 75 | 2 |
| South and Central American Synthetic API Market Revenue Share Analysis by Customer Base, 2005 2017 | 77 | 1 |
| South and Central American Biotech API Revenue Analysis by Customer Base, 2005 2017 | 78 | 2 |
| South and Central American Biotech API Revenue Share Analysis by Customer Base, 2005 2017 | 80 | 1 |
| South and Central American API Revenue Share Analysis by Therapeutic Applications | 81 | 2 |
| Appendix | 83 | 3 |
| Abbreviations | 83 | 1 |
| Market Definitions | 83 | 1 |
| References | 83 | 1 |
| Methodology | 84 | 2 |
| Coverage | 84 | 1 |
| Secondary Research | 84 | 1 |
| Primary Research | 85 | 1 |
| Expert Panel Validation | 85 | 1 |
| Contact Us | 85 | 1 |
| Disclaimer | 85 | 1 |
